Insider · CIK 0001294361

Crane Alan L

Reports to the SEC for 6 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001294361

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-04-01	Pandion Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−14K sh	—	—	0
2021-04-01	Pandion Therapeutics, Inc.U Disposition from Tender	Director, 10% Owner	UDisposition from Tender	−111K sh	$60.00	−$6.64M	0
2021-04-01	Pandion Therapeutics, Inc.U Disposition from Tender	Director, 10% Owner	UDisposition from Tender	−84.2K sh	$60.00	−$5.05M	0
2021-04-01	Pandion Therapeutics, Inc.U Disposition from Tender	Director, 10% Owner	UDisposition from Tender	−336K sh	$60.00	−$20.2M	0
2021-04-01	Pandion Therapeutics, Inc.U Disposition from Tender	Director, 10% Owner	UDisposition from Tender	−3.09M sh	$60.00	−$185M	0
2020-07-21	Pandion Therapeutics, Inc.Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.39M sh	—	—	0
2020-07-21	Pandion Therapeutics, Inc.Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−14.2M sh	—	—	0
2020-07-21	Pandion Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+14K sh	$18.00	+$252K	84,158
2020-07-21	Pandion Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+1,248 sh	$18.00	+$22.5K	110,621
2020-07-21	Pandion Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+34.9K sh	$18.00	+$628K	3,090,801
2020-07-21	Pandion Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+2.78M sh	—	—	2,783,892
2020-07-21	Pandion Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+272K sh	—	—	3,055,938
2020-07-21	Pandion Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+99.6K sh	—	—	99,637
2020-07-21	Pandion Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+9,736 sh	—	—	109,373
2020-07-21	Pandion Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+21.1K sh	—	—	70,158
2020-07-21	Pandion Therapeutics, Inc.Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−108K sh	—	—	0
2020-07-21	Pandion Therapeutics, Inc.Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−49.7K sh	—	—	0
2020-07-21	Pandion Therapeutics, Inc.Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−508K sh	—	—	0
2020-07-17	Pandion Therapeutics, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+14K sh	—	—	13,997
2016-06-22	DAREDare Bioscience, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+20K sh	—	—	20,000
2015-06-26	DAREDare Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+11K sh	—	—	11,000
2014-09-16	DAREDare Bioscience, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+16K sh	—	—	16,000
2014-09-16	DAREDare Bioscience, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−35.8K sh	—	—	0
2014-08-12	T2 Biosystems, Inc.P Purchase	Director	PPurchase	+30K sh	$11.00	+$330K	30,000
2010-04-14	MOMENTA PHARMACEUTICALS INCM Exercise/Conversion	Former Director	MExercise/Conversion	+6,600 sh	$0.99	+$6,534	585,202
2010-04-14	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Former Director	MExercise/Conversion	−6,600 sh	—	—	78,250
2010-04-14	MOMENTA PHARMACEUTICALS INCM Exercise/Conversion	Former Director	MExercise/Conversion	+28.6K sh	$4.91	+$140K	613,820
2010-04-14	MOMENTA PHARMACEUTICALS INCM Exercise/Conversion	Former Director	MExercise/Conversion	+6,600 sh	$0.99	+$6,534	585,220
2010-04-14	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Former Director	MExercise/Conversion	−28.6K sh	—	—	49,650
2010-04-14	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Former Director	MExercise/Conversion	−6,600 sh	—	—	78,250
2010-04-14	MOMENTA PHARMACEUTICALS INCM Exercise/Conversion	Former Director	MExercise/Conversion	+28.6K sh	$4.91	+$140K	613,802
2010-04-14	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Former Director	MExercise/Conversion	−28.6K sh	—	—	49,650
2007-06-13	MOMENTA PHARMACEUTICALS INCStock Option (Right to buy)A Award	Former Director	AAward	+19.2K sh	—	—	54,400
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−100 sh	$17.44	−$1,744	748,742
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−25K sh	$17.46	−$436K	723,773
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−200 sh	$17.47	−$3,494	723,573
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−400 sh	$17.48	−$6,992	723,173
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−100 sh	$17.49	−$1,749	723,073
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−371 sh	$17.51	−$6,496.21	722,702
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−100 sh	$17.55	−$1,755	722,602
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−100 sh	$17.56	−$1,756	722,502
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−1,600 sh	$17.60	−$28.2K	720,902
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−100 sh	$17.61	−$1,761	720,802
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−500 sh	$17.68	−$8,840	720,302
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−7,800 sh	$17.70	−$138K	712,502
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−4,100 sh	$17.75	−$72.8K	708,402
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−655 sh	$17.77	−$11.6K	707,747
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−267 sh	$17.78	−$4,747.26	707,480
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−8,082 sh	$17.80	−$144K	699,398
2006-12-08	MOMENTA PHARMACEUTICALS INCS Sale	Former Director	SSale	−556 sh	$17.84	−$9,919.04	698,842

Recent filings

Accepted (ET)
Apr 14
Crane Alan L0000899243-21-014462
SEC(opens sec.gov)
Jul 214
Crane Alan L0000899243-20-019884
SEC(opens sec.gov)
Jun 244
Cerulean Pharma Inc.0001209191-16-129528
SEC(opens sec.gov)

Companies

Address

C/O MOMENTA PHARMACEUTICALS 675 WEST KENDALL STREET

CAMBRIDGE, MA, 02142